Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05866003

tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia

After a stroke, it is very common to lose the ability to open the affected hand. Occupational and physical rehabilitation therapy (OT and PT) combined with non-invasive brain stimulation may help a person recover hand movement.

The purpose of this study is to compare 3 non-invasive brain stimulation protocols combined with therapy to see if they result in different amounts of recovery of hand movement after a stroke.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This study is a randomized clinical trail (RCT) of stroke survivors with chronic (6 to 24 months) hemiplegia randomized to: 1) conventional transcranial direct current stimulation (tDCS), 2) unconventional tDCS, or 3) sham tDCS during contralaterally controlled functional electrical stimulation mediated occupational therapy. The treatment will last 12 weeks and be followed by a 6-month follow-up period. Assessors, therapists and participants will be blinded to which tDCS treatment is received. This will be the first RCT of tDCS + CCFES.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 21 and ≤ 90
  • ≥ 6 and ≤ 24 months since first clinical hemorrhagic or nonhemorrhagic stroke
  • Able to follow 3-stage command
  • Able to remember 2 of 3 items after 30 minutes
  • Full volitional elbow extension/flexion and hand opening/closing of unaffected limb
  • Adequate active movement of shoulder and elbow to position the paretic hand in the workspace for table-top task practice
  • Patient must be able to sit unassisted in an armless straight-back chair for the duration of the screening portion of the eligibility assessment
  • Medically stable
  • ≥ 10° finger and wrist extension
  • Skin intact on hemiparetic arm, hand and scalp
  • Muscle contraction can be elicited with Transcranial Magnetic Stimulation
  • Unilateral upper limb hemiparesis with finger extensor strength of ≤ grade 4/5 on the Medical Research Council (MRC) scale
  • Score of ≥1/14 and ≤ 11/14 on the hand section of the upper extremity Fugl-Meyer Assessment
  • While relaxed, surface NMES of finger extensors and thumb extensors and/or abductors produces a functional degree of hand opening without pain.

Exclusion criteria

  • Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, PD, SCI, TBI, MS).
  • Uncontrolled seizure disorder
  • Use of seizure lowering threshold medications and the discretion of the study physician
  • Cardiac pacemaker or other implanted electronic device
  • Pregnant
  • IM Botox injections in any UE muscle in the last 3 months
  • Insensate arm, forearm, or hand
  • Deficits in communication that interfere with reasonable study participation
  • Severely impaired cognition and communication
  • Uncompensated hemi-neglect (extinguishing to double simultaneous stimulation)
  • Severe shoulder or hand pain (unable to position hand in the workspace without pain)

Treatment and study plan

Active conventional tDCS montage plus CCFES

Device

tDCS is a non-invasive brain stimulation technique. A small machine (9-volt battery operated device) will use a weak amount of electric current to stimulate the brain without any invasive procedure. Electrodes, covered in sponges soaked in saline, will be placed over certain parts of your head and held in place using a rubber strap. In addition, an electrical stimulator will be used to deliver electrical current through surface electrodes to produce hand opening by making the paretic finger and thumb extensor muscles contract.

Active unconventional tDCS montage plus CCFES

Device

tDCS is a non-invasive brain stimulation technique. A small machine (9-volt battery operated device) will use a weak amount of electric current to stimulate the brain without any invasive procedure. Electrodes, covered in sponges soaked in saline, will be placed over certain parts of your head and held in place using a rubber strap. In addition, An electrical stimulator will be used to deliver electrical current through surface electrodes to produce hand opening by making the paretic finger and thumb extensor muscles contract.

Sham tDCS plus CCFES

Device

An electrical stimulator will be used to deliver electrical current through surface electrodes to produce hand opening by making the paretic finger and thumb extensor muscles contract. The stimulator can be programmed to deliver stimulation with an intensity that corresponds to the opening of a glove instrumented with sensors and plugged into the stimulator.

CCFES with Occupational Therapy

Behavioral

An electrical stimulator will be used to deliver electrical current through surface electrodes to produce hand opening by making the paretic finger and thumb extensor muscles contract. The stimulator can be programmed to deliver stimulation with an intensity that corresponds to the opening of a glove instrumented with sensors and plugged into the stimulator. During the lab visits, all participants will use CCFES to assist hand opening during occupational therapy task practice.

Primary outcomes

  1. Box and Blocks Test (BBT)

    Time frame: Change in BBT will be assessed at 6 weeks, 12 weeks, 24 weeks, and 36 weeks

    The BBT counts how many blocks a patient can pick up, move over a barrier, and release in 60 seconds.

Secondary outcomes

  1. Upper Extremity Fugl-Meyer Assessment (UEFM).

    Time frame: Change in UEFM will be assessed at 6 weeks, 12 weeks, 24 weeks, and 36 weeks

    The UEFM is a reliable and valid measure of post-stroke upper limb motor impairment

Other outcomes

  1. Neurophysiologic Assessments

    Time frame: Change in neurophysiologic assessments will be assessed at 6 weeks, 12 weeks, 24 weeks, and 36 weeks

    Neurophysiologic assessments will be performed using TMS. Measures of excitability and inhibition will be measured.

Study contacts

Contact information is provided by the study sponsor or research team.

Amy Friedl, MS,OTR/L

CONTACT

[email protected]

216-957-3598

David Cunningham, PhD

CONTACT

[email protected]

216-957-3349

Sponsors and collaborators

Lead sponsor

MetroHealth Medical Center

Other

Registry information

Official study title

tDCS During Contralaterally Controlled FES for Upper Extremity Hemiplegia

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
May 19, 2023
Registry last updated
Sep 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.